Literature DB >> 17611960

The neuroendocrine system and rheumatoid arthritis: insights from anti-tumor necrosis factor-alpha therapy.

Esther M Sternberg, Marni N Silverman, Giovanni Cizza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611960

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism.

Authors:  Ravindra Shukla; Mayank Ganeshani; Monica Agarwal; Rakesh Jangir; Gaurav Kandel; Shrimanjunath Sankanagoudar; Shival Srivastava
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

2.  Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: an exploratory case-control study.

Authors:  Taavi Tillmann; Rajeev Krishnadas; Jonathan Cavanagh; K V Petrides
Journal:  Arthritis Res Ther       Date:  2013-03-21       Impact factor: 5.156

Review 3.  Does gamma-aminobutyric acid (GABA) influence the development of chronic inflammation in rheumatoid arthritis?

Authors:  James M Kelley; Laura B Hughes; S Louis Bridges
Journal:  J Neuroinflammation       Date:  2008-01-03       Impact factor: 8.322

4.  Use of the dexamethasone-corticotrophin releasing hormone test to assess hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis.

Authors:  Eman A Hasan; David S Jessop; Lynsey L Power; Paul T Monk; John R Kirwan
Journal:  Int J Endocrinol       Date:  2009-09-29       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.